These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 18161512

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J, Jun D, Kuca K.
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K.
    Toxicology; 2008 Jan 20; 243(3):311-6. PubMed ID: 18054821
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats.
    Kassa J, Karasova J.
    Drug Chem Toxicol; 2007 Jan 20; 30(2):117-31. PubMed ID: 17454028
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J, Karasova JZ, Bajgar J, Tesarova S, Kuca K, Musilek K.
    Basic Clin Pharmacol Toxicol; 2009 Mar 20; 104(3):228-35. PubMed ID: 19143747
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K, Kopelikova I.
    J Enzyme Inhib Med Chem; 2009 Aug 20; 24(4):1040-4. PubMed ID: 19552519
    [Abstract] [Full Text] [Related]

  • 13. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun.
    Kassa J, Kuca K, Karasova J, Musilek K.
    Mini Rev Med Chem; 2008 Oct 20; 8(11):1134-43. PubMed ID: 18855728
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J, Kunesova G.
    J Appl Toxicol; 2006 Oct 20; 26(4):309-16. PubMed ID: 16552727
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Evaluation of the Potency of Newly Developed Oximes (K727, K733) and Trimedoxime to Counteract Acute Neurotoxic Effects of Tabun in Rats.
    Kassa J, Hatlapatková J, Žďárová Karasová J.
    Acta Medica (Hradec Kralove); 2015 Oct 20; 58(4):135-43. PubMed ID: 26960827
    [Abstract] [Full Text] [Related]

  • 17. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K, Cabal J, Kassa J, Jun D, Hrabinova M.
    J Toxicol Environ Health A; 2006 Aug 20; 69(15):1431-40. PubMed ID: 16766478
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats.
    Kassa J, Karasova J.
    J Toxicol Environ Health A; 2007 Sep 20; 70(18):1556-67. PubMed ID: 17710615
    [Abstract] [Full Text] [Related]

  • 20. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L, Kuca K, Jun D, Kunesova G.
    Int J Toxicol; 2005 Sep 20; 24(6):399-402. PubMed ID: 16393932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.